Year 2016 is ending with very good results for HCS Pharma, with a nice and motivated team, the effective launch of partnerships with the “Insitut du Thorax” in Nantes and Inserm U991 in Rennes, and customers partners that reiterate their trust. 2017 will be the year of our strengthening, with new labs in Lille, completing those of Rennes. We will thus enhance our collaborations and know-how in the fields of neurosciences and cancer research. The installation in Lille will also give us the in-house ability to screen full compound libraries, either on 2D cell cultures or 3D microtissues.
Goodbye 2016, welcome 2017 ! 


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

Leave a Reply